Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2026-03-08 @ 1:58 AM
Study NCT ID:
NCT07285369
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-16
First Post:
2025-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)
Sponsor:
Agyany Pharma LTD
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AGP3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None